News

Soleno Therapeutics Strengthens Leadership Team with Key Appointments

REDWOOD CITY, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing…

2 years ago

Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust

MOUNTAIN VIEW, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation, headquartered in Mountain View, California, and Imperial College Healthcare…

2 years ago

Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

Pre-print publication from Levy, et al. describes the second phase of a multisite evaluation and validation of optical genome mapping (OGM) that…

2 years ago

HealthLynked and CEO Dr. Michael Dent Featured in Health Documentary “Forever: The End of Aging,” Now Available for Streaming 

HealthLynked and CEO Dr. Michael Dent Featured in Health Documentary "Forever: The End of Aging," Now Available for StreamingNAPLES, Fla.,…

2 years ago

ZyVersa Therapeutics Announces Peer-Reviewed Article Supporting the Therapeutic Potential of Targeting ASC Specks During Progression of Alzheimer’s Disease

Research demonstrated that activation of the inflammasome/ASC speck pathway has a vital role in synaptic degeneration in Alzheimer’s Disease (AD).ZyVersa…

2 years ago

SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement

TEL AVIV, Israel, Jan. 24, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical…

2 years ago

Venus Concept Inc. Announces Review of Strategic Alternatives

TORONTO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical…

2 years ago

Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in Humans

NEW YORK, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage…

2 years ago

USPTO Grants Registered Trademark Status for “Fiber UP” – An Innovative New Breakthrough In Fiber Supplementation From Glucose Health, Inc. (OTCPK: GLUC)

BENTONVILLE, Ark., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Glucose Health, Inc., the pioneer in delicious manufacturing prebiotic soluble fiber enriched…

2 years ago

Kura Oncology Announces Oversubscribed $150 Million Private Placement

– Funding from existing investors, including EcoR1 Capital, an affiliate of Deerfield Management and Suvretta Capital – – Pro forma…

2 years ago